EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mid‐ to Long‐Term Clinical Outcomes of Cartilage Restoration of Knee Joint with Allogenic Next‐Generation Matrix‐Induced Autologous Chondrocyte Implantation ( MACI )

Yufeng Liu iD, Ning Ma, Zhe Zhao, Quanyi Guo

Orthopaedic Surgery · 2023-02 · 15 (2) · 549-562

DOI: 10.1111/os.13662 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Orthopaedic Surgery, online erschienen am 17.01.2023. Verfasst von Yufeng Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Orthopedic, Chinese PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Chondrocytes, Cartilage, Articular. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Cartilage defect is a common pathology still lacking a unified treating option. The purpose of this retrospective study is to evaluate the safety, efficacy, and clinical and radiological outcome of cartilage restoration of knee joint with allogenic next‐generation Matrix‐Induced Autologous Chondrocyte Implantation (MACI) for the first time, as well as the correlation between postoperative clinical and radiological outcomes and preoperative patient history and demographics.

Methods

From July 2014 to August 2020, 15 patients who went through cartilage restoration with allogenic next‐generation MACI were included in this study. Patient demographics and PROM including the International Knee Documentation Committee (IKDC) subjective knee score, Lysholm score, Tegner Activity Scale (TAS), and Knee Injury and Osteoarthritis Outcome Score (KOOS) were obtained preoperatively, at 3, 6, 12 months postoperatively and the last follow‐up using an online questionnaire platform. MOCART 2.0 score was calculated at the last follow‐up. Analysis of variance (ANOVA) was used to compare PROM pre‐ and post‐operation, with two‐tailed p < 0.05 defined as statistical significant. Pearson correlation coefficient was used to evaluate correlation between the PROM and MOCART 2.0 score at the last follow‐up with patients demorgraphics.

Results

All patients were followed for an average of 66.47 ± 24.15 months (range, 21–93). All patients were satisfied with the outcome of the surgery and no complication was reported at the end of the study. No significant improvement was observed until 1 year after the implantation, except for IKDC score at 6 months. All PROM showed significant improvement 1 year post‐op except for Lysholm score and TAS, which also increased significantly at the time of the last follow‐up. Pearson correlation coefficient showed that the size of the defect, before or after debridement, was significantly negatively correlated with final KOOS‐Pain (before debridement: r = −0.57, p < 0.05; after debridement: r = −0.54, p < 0.05) and KOOS‐Symptoms score (before debridement: r = −0.66, p < 0.05; after debridement: r = −0.67, p < 0.05). The MOCART 2.0 score was found significantly and negatively correlated with BMI ( r = −0.60, p < 0.05), and significantly and positively correlated with Lysholm score ( r = 0.70, p < 0.05).

Conclusion

The next generation MACI with autologous chondrocyte and allogenic chondrocyte ECM scaffold could be used to treat focal articular cartilage defect in the knee joint safely and efficiently with lasting promising outcomes for more than 5 years. The size of the defects should be considered the most negatively correlated parameters influencing the postoperative clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChondrocytesCartilage, ArticularHumansFollow-Up StudiesRetrospective StudiesMagnetic Resonance ImagingTransplantation, AutologousKnee Joint

Stichwörter der Autor:innen

CartilageChondral DefectMACIMatrix-Induced Autologous Chondrocyte ImplantationTissue Engineer

Autor:innen und Institutionen

  • Institute of Orthopedic, Chinese PLA General Hospital, Beijing, China.
  • Department of Sports Medicine, Chinese PLA General Hospital, Beijing, China.

ORCID-Profile: Yufeng Liu

Zitieren

APA

Liu, Y., Ma, N., Zhao, Z., & Guo, Q. (2023). Mid‐ to Long‐Term Clinical Outcomes of Cartilage Restoration of Knee Joint with Allogenic Next‐Generation Matrix‐Induced Autologous Chondrocyte Implantation ( MACI ). Orthopaedic Surgery, 15(2), 549-562. https://doi.org/10.1111/os.13662

Vancouver

Liu Y, Ma N, Zhao Z, Guo Q. Mid‐ to Long‐Term Clinical Outcomes of Cartilage Restoration of Knee Joint with Allogenic Next‐Generation Matrix‐Induced Autologous Chondrocyte Implantation ( MACI ). Orthopaedic Surgery. 2023;15(2):549-562. doi:10.1111/os.13662

BibTeX
@article{Liu2023,
  author = {Liu, Yufeng and Ma, Ning and Zhao, Zhe and Guo, Quanyi},
  title = {Mid‐ to Long‐Term Clinical Outcomes of Cartilage Restoration of Knee Joint with Allogenic Next‐Generation Matrix‐Induced Autologous Chondrocyte Implantation ( MACI )},
  journal = {Orthopaedic Surgery},
  year = {2023},
  volume = {15},
  number = {2},
  pages = {549--562},
  doi = {10.1111/os.13662}
}
Kostenlos starten →